Hoffman Michael B 4

What Happened

• Michael B. Hoffman, a director of Annovis Bio, acquired 713,800 shares in an open-market purchase on April 2, 2026. The shares were bought at $2.10 per share, for a total cash outlay of $1,498,980. This was a purchase (inflow of personal capital), not a sale.

Key Details

• Transaction date and price: 2026-04-02 — Purchase at $2.10 per share.
• Total shares acquired: 713,800; total value: $1,498,980.
• Shares owned after transaction: Not specified in this filing.
• Footnote: Shares are held in a family trust formed by the reporting person; Hoffman has voting and investment power over those shares (F1).
• Filing timeliness: Report filed 2026-04-03 for a 2026-04-02 transaction (filed the next day; not noted as late).

Context

• This was an outright open-market purchase (code P), which is generally more informative to investors than routine sales because it reflects an insider buying stock.
• No options, awards, gifts, or tax-withholding details were reported in this Form 4.